Full Name
Sham Sokka
Job Title
Chief Operating & Technology Officer, Digital Health
Company
RadNet
Speaker Bio
Sham Sokka, PhD is currently the Chief Operating and Technology Officer of Digital Health at RadNet. RadNet is an industry-leading provider of high-quality, cost-effective diagnostic imaging services and enabling health informatics solutions. Dr. Sokka joined the management team of RadNet in June 2023 to drive RadNet’s health informatics roadmap accelerating the digitization, automation, and scalability of healthcare diagnostics services.
Prior to joining RadNet, Sham held several global executive-level roles in business, marketing, and innovation during his 20-year tenure at Philips. Most recently he served as Senior Vice-President of Innovation and Marketing for the Precision Diagnosis business cluster. The Precision Diagnosis business with $6B+ in revenues included diagnostic imaging, ultrasound, enterprise diagnostic informatics (solutions such as PACS & digital pathology), and related radiology, oncology, and cardiology solutions. Philips is a pioneer in Precision Diagnosis developing solutions that integrate various diagnostics to guide patients through optimal pathways and outcomes. As the innovation & marketing leader, he directed R&D and the innovation strategy and was responsible for portfolios, and strategic and downstream marketing for the business cluster.
Prior to that role, he led informatics and services businesses: the Ventures and Radiology Solutions businesses of that same cluster. Sham and the Radiology Solutions team were responsible for developing comprehensive imaging solutions. These solutions integrate imaging modalities, informatics, data, workflows, and services through novel software applications that enable better and more efficient healthcare delivery. In this role, he started and led the tele-radiology, diagnostic command center, and patient management solutions businesses while also developing other early-stage opportunities.
Previously, Sham held the role of CTO and director of Research and clinical Science for the Philips MR Therapy business including emerging products, MR-HIFU, MR-LINAC, MR-OR, and interventional MR suites, playing a leading role in Philips MR in Oncology, Radiation Therapy, and Image-guided Interventions & Therapy business entry. In this role, he also started and ran clinical trials from phase I IDE to phase III FDA PMA studies for these emerging medical devices.
Dr. Sokka obtained his PhD in 2004 in Electrical & Medical Engineering from MIT through the Harvard-MIT Health Sciences & Technology program, a joint engineering and clinical medicine training program. His dissertation topic was in MR-guided focused ultrasound specifically on cavitation and heating mechanisms critical to thermal ablation and focused ultrasound-mediated drug delivery. In 2003, he joined Philips Research as a senior scientist in the area of diagnostic ultrasound and ultrasound-mediated drug delivery. While at Philips Research, he also managed programs in the area of operator-independent ultrasound, cardiac-focused ultrasound therapy, and multi-modality imaging for clinical electrophysiology interventions. Sham holds over 50 publications and patents in the area of therapeutic ultrasound, ultrasound imaging, MR-guided interventions, and multi-modality image guidance for interventions.
Prior to joining RadNet, Sham held several global executive-level roles in business, marketing, and innovation during his 20-year tenure at Philips. Most recently he served as Senior Vice-President of Innovation and Marketing for the Precision Diagnosis business cluster. The Precision Diagnosis business with $6B+ in revenues included diagnostic imaging, ultrasound, enterprise diagnostic informatics (solutions such as PACS & digital pathology), and related radiology, oncology, and cardiology solutions. Philips is a pioneer in Precision Diagnosis developing solutions that integrate various diagnostics to guide patients through optimal pathways and outcomes. As the innovation & marketing leader, he directed R&D and the innovation strategy and was responsible for portfolios, and strategic and downstream marketing for the business cluster.
Prior to that role, he led informatics and services businesses: the Ventures and Radiology Solutions businesses of that same cluster. Sham and the Radiology Solutions team were responsible for developing comprehensive imaging solutions. These solutions integrate imaging modalities, informatics, data, workflows, and services through novel software applications that enable better and more efficient healthcare delivery. In this role, he started and led the tele-radiology, diagnostic command center, and patient management solutions businesses while also developing other early-stage opportunities.
Previously, Sham held the role of CTO and director of Research and clinical Science for the Philips MR Therapy business including emerging products, MR-HIFU, MR-LINAC, MR-OR, and interventional MR suites, playing a leading role in Philips MR in Oncology, Radiation Therapy, and Image-guided Interventions & Therapy business entry. In this role, he also started and ran clinical trials from phase I IDE to phase III FDA PMA studies for these emerging medical devices.
Dr. Sokka obtained his PhD in 2004 in Electrical & Medical Engineering from MIT through the Harvard-MIT Health Sciences & Technology program, a joint engineering and clinical medicine training program. His dissertation topic was in MR-guided focused ultrasound specifically on cavitation and heating mechanisms critical to thermal ablation and focused ultrasound-mediated drug delivery. In 2003, he joined Philips Research as a senior scientist in the area of diagnostic ultrasound and ultrasound-mediated drug delivery. While at Philips Research, he also managed programs in the area of operator-independent ultrasound, cardiac-focused ultrasound therapy, and multi-modality imaging for clinical electrophysiology interventions. Sham holds over 50 publications and patents in the area of therapeutic ultrasound, ultrasound imaging, MR-guided interventions, and multi-modality image guidance for interventions.
Speaking At
